跳至主要内容
临床试验/NCT01052324
NCT01052324已完成4 期

The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation

Yonsei University2 个研究点 分布在 2 个国家目标入组 19 人开始时间: 2010年3月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
19
试验地点
2
主要终点
EC50 of remifentanil for preventing persistent cough and defensive movement using Dixon's up-and-down method

研究概览

简要总结

Remifentanil provides analgesia, suppresses airway reflex, has little effect on cognitive function. It can be used for conscious sedation during awake nasotracheal fiberoptic intubation. Target-controlled infusion is more reliable technique for maintaining optimal infusion rate than manual controlled infusion. The aim of this study is to determine the effect site concentration of remifentanil for successful conscious sedation during awake nasotracheal fiberoptic intubation.

研究设计

研究类型
Interventional
主要目的
Prevention

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing cervical spine surgery
  • Age 20-65
  • American Society of Anesthesiologists physical status classification I or II

排除标准

  • Patients' refusal
  • allergy to any drug used
  • unable to cooperate
  • Severe hepatic or renal disease
  • coagulation disorder
  • chronic use of opioids or sedatives
  • increase risk of pulmonary aspiration.

结局指标

主要结局

EC50 of remifentanil for preventing persistent cough and defensive movement using Dixon's up-and-down method

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验